Dr. David Wald on Immunotherapy Platforms and U.S.-Saudi Clinical Trial Collaboration
- Share via
Dr. David Wald, Professor in the Department of Pathology at Case Western Reserve University School of Medicine and Co-Leader of the Immune Oncology Program at Case Comprehensive Cancer Center, discusses what people should know about immunotherapy platforms and how they’re transforming cancer treatment.
